Fabino Life Sciences informs about revised outcome of board meeting

24 Nov 2022 Evaluate
Fabino Life Sciences has informed that in continuation of letter dated November 02, 2022 and pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Unaudited Financial Results set out in compliance with Accounting Standards (AS) for the Half Year ended September 30, 2022 , duly approved by the Board of Directors of the Company in their meeting held on November 09, 2022 together with Statement of Assets and Liabilities, Cash Flow and Limited Review Report thereon are enclosed.

The above information is a part of company’s filings submitted to BSE.

Fabino Enterprises Share Price

28.00 0.00 (0.00%)
08-Nov-2024 00:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.